Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FcεRI: A Master Regulator of Mast Cell Functions. | Cells | 2022 | 35203273 | PubTator, text mining | PubMed |
| CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism. | Theranostics | 2022 | 35198053 | PubTator, text mining | PubMed |
| Can epigenetics shine a light on the biological pathways underlying major mental disorders? | Psychol Med | 2022 | 35193719 | PubTator, text mining | PubMed |
| Strategies Towards Antigen-Specific Treatments for Membranous Nephropathy. | Front Immunol | 2022 | 35185913 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the multi-cellular ecosystem in different radiological components of pulmonary part-solid nodules. | Clin Transl Med | 2022 | 35184398 | PubTator, text mining | PubMed |
| Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases. | Neurotherapeutics | 2022 | 35182380 | PubTator, text mining | PubMed |
| Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. | Ann Rheum Dis | 2022 | 35168946 | PubTator, text mining | PubMed |
| Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity. | Int J Mol Sci | 2022 | 35163400 | PubTator, text mining | PubMed |
| Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. | Cells | 2022 | 35159250 | PubTator, text mining | PubMed |
| Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2022 | 35158929 | PubTator, text mining | PubMed |
| Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. | Cancers (Basel) | 2022 | 35158779 | PubTator, text mining | PubMed |
| Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation. | Front Immunol | 2022 | 35154135 | PubTator, text mining | PubMed |
| Allergic rhinitis, allergic contact dermatitis and disease comorbidity belong to separate entities with distinct composition of T-cell subsets, cytokines, immunoglobulins and autoantibodies. | Allergy Asthma Clin Immunol | 2022 | 35148790 | PubTator, text mining | PubMed |
| Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial. | Cell Rep | 2022 | 35139373 | PubTator, text mining | PubMed |
| The PD-L1/4-1BB Bispecific Antibody-Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner. | Clin Cancer Res | 2022 | 35121624 | PubTator, text mining | PubMed |
| The tangled web of autoreactive B cells in malaria immunity and autoimmune disease. | Trends Parasitol | 2022 | 35120815 | PubTator, text mining | PubMed |
| Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis. | Nat Commun | 2022 | 35115533 | PubTator, text mining | PubMed |
| Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients. | Infect Dis Poverty | 2022 | 35109926 | PubTator, text mining | PubMed |
| Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection. | Trends Mol Med | 2022 | 35093288 | PubTator, text mining | PubMed |
| Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies. | Neurotherapeutics | 2022 | 35084720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=52